Chemical Structure : SZM-1209
Catalog No.: PC-24512Not For Human Use, Lab Use Only.
SZM-1209 is a potent, specific RIPK1 inhibitor with Kd value of 85 nM, >100-fold selective over RIPK3, exhibits anti-necroptosis activity against human HT-29 cells with EC50 of 22.4 nM.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
SZM-1209 is a potent, specific RIPK1 inhibitor with Kd value of 85 nM, >100-fold selective over RIPK3, exhibits anti-necroptosis activity against human HT-29 cells with EC50 of 22.4 nM.
SZM-1209 specifically inhibits necroptosis signaling rather apoptosis, dose-relatedly inhibits necroptosis and almost 100% protectionat 50 nM.
SZM-1209 specifically inhibits phosphorylation of RIPK1-RIPK3-MLKL necroptosis signaling.
SZM-1209 (10 and 20 mg/kg) effectively protect against mTNFα-induced systemic inflammatory response syndrome (SIRS) model in vivo.
SZM-1209 significantly alleviated ALI by reducing pulmonary edema and pathological damage in NNK short-term intratracheal exposure-induced ALI model.
M.Wt | 696.71 | |
Formula | C31H29F5N4O5S2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Zhang X, et al. J Med Chem. 2023 Apr 13;66(7):5261-5278.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright